Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistanceMeghna Das Thakur, Darrin D. Stuart, Nancy Pryer et al.|Nature|2013Cited by 735
Design, Structure–Activity Relationship, and in Vivo Characterization of the Development Candidate NVP-HSP990Christopher M. McBride, Cynthia M. Shafer, Barry H. Levine et al.|Journal of Medicinal Chemistry|2014Cited by 28